address was entitled ' Pharmacologically Active Substances normally present in the Brain.'
Professor Gaddum gave a general account of the pharmacological analysis of tissue extracts with special reference to recent work on extracts of the brain. This work had grown out of the experiments by Oliver and Schafer in 1895 when they found that extracts of the adrenal glands and the pituitary glands caused a rise of blood-pressure and that extracts of other tissues caused a fall. A large number of active substances had been found in these extracts. Histamine was first isolated from extracts of ergot and later found in mammalian tissues. Many details were now known about its distribution in the body and it had been shown to play a part in anaphylaxis and allergy. It was generally felt, without clear evidence, that it must have some physiological function apart from the part which it plays in response to injury. Acetylcholine was first isolated from ergot and from tlie spleens of horses and had been shown to be liberated by many nerves. It was also present in extracts of the nerve trunks and this fact had been used to study the distribution in the body of the nerves which liberate it. This fact has stimulated interest in the study of other substances in extracts because of the possibility that they may also be liberated as chemical transmitters at nerve endings. Noradrenaline is found in adrenergic nerves and in certain part? of the central nervous system. Two newer substances are also present in some parts of the central nervous system ?one of these, substance I', is a polypeptide of unknown structure and the other ?~>-hydroxytryptamine (HT), has been isolated in the pure state. Methods have been developed for estimating these in tissues and some of the results were presented.
Noradrenaline and HT are in tissues such as the hypothalamus and mid-brain which are associated with the central connections of the sympathetic system. An ergot derivative, which is known as LSD, or lysergic acid diethylamide, in small doses causes a condition resembling schizophrenia. It is also a powerful antagonist of HT and may produce its effects by inhibiting the normal activities of the HT which is present in the brain. Substance I' appears to be specifically present in the Posterior spinal routes and may perhaps be liberated as a chemical transmitter in the nuclei gracilis and cuneatus, and is also present in the caudate nucleus.
More work will be needed before the meaning of this work can be known for certain.
33U
